Rush University Medical Center_Investigational Site Number 84029 — Chicago, Illinois

Rush University Medical Center_Investigational Site Number 84029 is a clinical research site located in Chicago, Illinois, United States 60612.

Crixeo Clinical Trials Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Rush University Medical Center_Investigational Site Number 84029 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Immune Thrombocytopenia.

Sponsors: Principia Biopharma, a Sanofi Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chicago

Browse all research sites in Illinois · View every site in Chicago

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rush University Medical Center_Investigational Site Number 84029?

Rush University Medical Center_Investigational Site Number 84029 has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rush University Medical Center_Investigational Site Number 84029 conducted?

Rush University Medical Center_Investigational Site Number 84029 has 1 clinical trials on record, with 1 currently active. Their work covers Immune Thrombocytopenia.

Is Rush University Medical Center_Investigational Site Number 84029 accredited by Crixeo Clinical Trials?

Rush University Medical Center_Investigational Site Number 84029 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rush University Medical Center_Investigational Site Number 84029?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.